Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Change in Inventory (2020 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Change in Inventory for 6 consecutive years, with $581000.0 as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 28.45% to $581000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Dec 2025, up 219.52% year-over-year, with the annual reading at $5.9 million for FY2025, 219.52% up from the prior year.
  • Change in Inventory hit $581000.0 in Q4 2025 for Eton Pharmaceuticals, up from -$5.6 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $11.4 million in Q2 2025 to a low of -$5.6 million in Q3 2025.
  • Historically, Change in Inventory has averaged $467388.9 across 5 years, with a median of $48500.0 in 2022.
  • Biggest YoY gain for Change in Inventory was 4650.8% in 2025; the steepest drop was 4218.46% in 2025.
  • Year by year, Change in Inventory stood at $216000.0 in 2021, then plummeted by 64.81% to $76000.0 in 2022, then tumbled by 264.47% to -$125000.0 in 2023, then surged by 749.6% to $812000.0 in 2024, then fell by 28.45% to $581000.0 in 2025.
  • Business Quant data shows Change in Inventory for ETON at $581000.0 in Q4 2025, -$5.6 million in Q3 2025, and $11.4 million in Q2 2025.